{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T08:42:34Z","timestamp":1722760954664},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00204-020-02749-8","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T16:02:37Z","timestamp":1587225757000},"page":"2523-2541","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1\/N mice"],"prefix":"10.1007","volume":"94","author":[{"given":"Haruhiro","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sailesh","family":"Surapureddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh C.","family":"Kovi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Bhusari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thai Vu","family":"Ton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Shockley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyamal D.","family":"Peddada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin E.","family":"Gerrish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia V.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Hoenerhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Sills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun R.","family":"Pandiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,18]]},"reference":[{"issue":"1","key":"2749_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc: Ser B (Methodol) 57(1):289\u2013300","journal-title":"J R Stat Soc: Ser B (Methodol)"},{"issue":"2","key":"2749_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19(2):185\u2013193. https:\/\/doi.org\/10.1093\/bioinformatics\/19.2.185","journal-title":"Bioinformatics"},{"issue":"11","key":"2749_CR3","doi-asserted-by":"publisher","first-page":"e111855","DOI":"10.1371\/journal.pone.0111855","volume":"9","author":"W Bouhaddioui","year":"2014","unstructured":"Bouhaddioui W, Provost PR, Tremblay Y (2014) Identification of most stable endogenous control genes for microRNA quantification in the developing mouse lung. PLoS ONE 9(11):e111855. https:\/\/doi.org\/10.1371\/journal.pone.0111855","journal-title":"PLoS ONE"},{"issue":"5","key":"2749_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/ajh.2010.14","volume":"23","author":"TE Brinkley","year":"2010","unstructured":"Brinkley TE, Lovato JF, Arnold AM et al (2010) Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. Am J Hypertens 23(5):528\u2013533. https:\/\/doi.org\/10.1038\/ajh.2010.14","journal-title":"Am J Hypertens"},{"key":"2749_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.fct.2018.05.013","volume":"118","author":"NR Catlin","year":"2018","unstructured":"Catlin NR, Collins BJ, Auerbach SS et al (2018) How similar is similar enough? A sufficient similarity case study with Ginkgo biloba extract. Food Chem Toxicol 118:328\u2013339. https:\/\/doi.org\/10.1016\/j.fct.2018.05.013","journal-title":"Food Chem Toxicol"},{"issue":"46","key":"2749_CR6","doi-asserted-by":"publisher","first-page":"35293","DOI":"10.1074\/jbc.M110.160069","volume":"285","author":"CL Cottonham","year":"2010","unstructured":"Cottonham CL, Kaneko S, Xu L (2010) miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem 285(46):35293\u201335302. https:\/\/doi.org\/10.1074\/jbc.M110.160069","journal-title":"J Biol Chem"},{"issue":"8","key":"2749_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tcb.2010.05.002","volume":"20","author":"G Davidson","year":"2010","unstructured":"Davidson G, Niehrs C (2010) Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol 20(8):453\u2013460. https:\/\/doi.org\/10.1016\/j.tcb.2010.05.002","journal-title":"Trends Cell Biol"},{"issue":"19","key":"2749_CR8","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1001\/jama.2008.683","volume":"300","author":"ST DeKosky","year":"2008","unstructured":"DeKosky ST, Williamson JD, Fitzpatrick AL et al (2008) Ginkgo biloba for prevention of dementia a randomized controlled trial. JAMA J Am Med Assoc 300(19):2253\u20132262. https:\/\/doi.org\/10.1001\/jama.2008.683","journal-title":"JAMA J Am Med Assoc"},{"issue":"1","key":"2749_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.psc.2012.12.006","volume":"36","author":"BJ Diamond","year":"2013","unstructured":"Diamond BJ, Bailey MR (2013) Ginkgo biloba: indications, mechanisms, and safety. Psychiatr Clin N Am 36(1):73\u201383. https:\/\/doi.org\/10.1016\/j.psc.2012.12.006","journal-title":"Psychiatr Clin N Am"},{"issue":"5","key":"2749_CR10","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.1007\/s13277-015-4462-3","volume":"37","author":"W Ding","year":"2016","unstructured":"Ding W, Tan H, Zhao C et al (2016) MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma. Tumour Biol 37(5):6255\u20136260. https:\/\/doi.org\/10.1007\/s13277-015-4462-3","journal-title":"Tumour Biol"},{"issue":"2","key":"2749_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/CBM-170568","volume":"19","author":"Z Du","year":"2017","unstructured":"Du Z, Niu S, Xu X, Xu Q (2017) MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistance. Cancer Biomark 19(2):221\u2013230. https:\/\/doi.org\/10.3233\/CBM-170568","journal-title":"Cancer Biomark"},{"key":"2749_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.pharmthera.2017.02.010","volume":"173","author":"R Dutta","year":"2017","unstructured":"Dutta R, Mahato RI (2017) Recent advances in hepatocellular carcinoma therapy. Pharmacol Ther 173:106\u2013117. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.010","journal-title":"Pharmacol Ther"},{"key":"2749_CR13","unstructured":"EMA\/HMPC\/321095\/2012 (2014) Assessment report on Ginkgo biloba L., folium. European Medicines Agency"},{"key":"2749_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1747-1028-5-11","volume":"5","author":"JM Enserink","year":"2010","unstructured":"Enserink JM, Kolodner RD (2010) An overview of Cdk1-controlled targets and processes. Cell Div 5:11. https:\/\/doi.org\/10.1186\/1747-1028-5-11","journal-title":"Cell Div"},{"issue":"7212","key":"2749_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature07179","volume":"455","author":"R Firestein","year":"2008","unstructured":"Firestein R, Bass AJ, Kim SY et al (2008) CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455(7212):547\u2013551. https:\/\/doi.org\/10.1038\/nature07179","journal-title":"Nature"},{"issue":"43","key":"2749_CR16","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1038\/onc.2008.178","volume":"27","author":"F Fornari","year":"2008","unstructured":"Fornari F, Gramantieri L, Ferracin M et al (2008) MiR-221 controls CDKN1C\/p57 and CDKN1B\/p27 expression in human hepatocellular carcinoma. Oncogene 27(43):5651\u20135661. https:\/\/doi.org\/10.1038\/onc.2008.178","journal-title":"Oncogene"},{"issue":"5","key":"2749_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.biocel.2012.02.004","volume":"44","author":"LL Fu","year":"2012","unstructured":"Fu LL, Wen X, Bao JK, Liu B (2012) MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 44(5):733\u2013736. https:\/\/doi.org\/10.1016\/j.biocel.2012.02.004","journal-title":"Int J Biochem Cell Biol"},{"issue":"13","key":"2749_CR18","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","volume":"67","author":"L Gramantieri","year":"2007","unstructured":"Gramantieri L, Ferracin M, Fornari F et al (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67(13):6092\u20136099. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4607","journal-title":"Cancer Res"},{"key":"2749_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/nar\/gkh023","volume":"32","author":"S Griffiths-Jones","year":"2004","unstructured":"Griffiths-Jones S (2004) The microRNA registry. Nucleic Acids Res 32:109\u2013111. https:\/\/doi.org\/10.1093\/nar\/gkh023","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2749_CR20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jpsychires.2012.03.003","volume":"46","author":"H Herrschaft","year":"2012","unstructured":"Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S (2012) Ginkgo biloba extract EGb 761(R) in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J Psychiatr Res 46(6):716\u2013723. https:\/\/doi.org\/10.1016\/j.jpsychires.2012.03.003","journal-title":"J Psychiatr Res"},{"issue":"6","key":"2749_CR21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1177\/0192623312467520","volume":"41","author":"MJ Hoenerhoff","year":"2013","unstructured":"Hoenerhoff MJ, Pandiri AR, Snyder SA et al (2013) Hepatocellular carcinomas in B6C3F1 mice treated with Ginkgo biloba extract for two years differ from spontaneous liver tumors in cancer gene mutations and genomic pathways. Toxicol Pathol 41(6):826\u2013841. https:\/\/doi.org\/10.1177\/0192623312467520","journal-title":"Toxicol Pathol"},{"issue":"2","key":"2749_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ccr.2011.01.001","volume":"19","author":"J Hou","year":"2011","unstructured":"Hou J, Lin L, Zhou W et al (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a\/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19(2):232\u2013243. https:\/\/doi.org\/10.1016\/j.ccr.2011.01.001","journal-title":"Cancer Cell"},{"key":"2749_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/nar\/gkq1107","volume":"39","author":"SD Hsu","year":"2011","unstructured":"Hsu SD, Lin FM, Wu WY et al (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39:163\u2013169. https:\/\/doi.org\/10.1093\/nar\/gkq1107","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2749_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cas.12869","volume":"107","author":"L Huan","year":"2016","unstructured":"Huan L, Bao C, Chen D et al (2016) MicroRNA-127-5p targets the biliverdin reductase B\/nuclear factor-kappaB pathway to suppress cell growth in hepatocellular carcinoma cells. Cancer Sci 107(3):258\u2013266. https:\/\/doi.org\/10.1111\/cas.12869","journal-title":"Cancer Sci"},{"issue":"4","key":"2749_CR25","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/ijc.23580","volume":"123","author":"S Huang","year":"2008","unstructured":"Huang S, He X, Ding J et al (2008) Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 123(4):972\u2013978. https:\/\/doi.org\/10.1002\/ijc.23580","journal-title":"Int J Cancer"},{"issue":"3","key":"2749_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4(3):143\u2013159. https:\/\/doi.org\/10.1002\/emmm.201100209","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2749_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000012140","volume":"59","author":"Y Ito","year":"2000","unstructured":"Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N (2000) Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology 59(1):68\u201374. https:\/\/doi.org\/10.1159\/000012140","journal-title":"Oncology"},{"issue":"10","key":"2749_CR28","doi-asserted-by":"publisher","first-page":"8089","DOI":"10.18632\/oncotarget.3512","volume":"6","author":"HS Kim","year":"2015","unstructured":"Kim HS, Lee KS, Bae HJ et al (2015) MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial\u2013mesenchymal transition regulatory proteins in liver cancer. Oncotarget 6(10):8089\u20138102. https:\/\/doi.org\/10.18632\/oncotarget.3512","journal-title":"Oncotarget"},{"issue":"8","key":"2749_CR29","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s00204-019-02505-7","volume":"93","author":"RC Kovi","year":"2019","unstructured":"Kovi RC, Bhusari S, Mav D et al (2019) Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1\/N mice. Arch Toxicol 93(8):2219\u20132235. https:\/\/doi.org\/10.1007\/s00204-019-02505-7","journal-title":"Arch Toxicol"},{"issue":"1","key":"2749_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/Circoutcomes.109.871640","volume":"3","author":"LH Kuller","year":"2010","unstructured":"Kuller LH, Ives DG, Fitzpatrick AL et al (2010) Does Ginkgo biloba reduce the risk of cardiovascular events? Circ-Cardiovasc Qual 3(1):41\u2013U71. https:\/\/doi.org\/10.1161\/Circoutcomes.109.871640","journal-title":"Circ-Cardiovasc Qual"},{"issue":"12","key":"2749_CR31","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/gcc.22107","volume":"52","author":"EM Laurila","year":"2013","unstructured":"Laurila EM, Kallioniemi A (2013) The diverse role of miR-31 in regulating cancer associated phenotypes. Genes Chromosomes Cancer 52(12):1103\u20131113. https:\/\/doi.org\/10.1002\/gcc.22107","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"2749_CR32","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/carcin\/bgs130","volume":"33","author":"PT Law","year":"2012","unstructured":"Law PT, Ching AK, Chan AW et al (2012) MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. Carcinogenesis 33(6):1134\u20131141. https:\/\/doi.org\/10.1093\/carcin\/bgs130","journal-title":"Carcinogenesis"},{"issue":"17","key":"2749_CR33","doi-asserted-by":"publisher","first-page":"28683","DOI":"10.18632\/oncotarget.15640","volume":"8","author":"C Li","year":"2017","unstructured":"Li C, Miao R, Liu S et al (2017) Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis. Oncotarget 8(17):28683\u201328695. https:\/\/doi.org\/10.18632\/oncotarget.15640","journal-title":"Oncotarget"},{"issue":"7","key":"2749_CR34","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4103\/0366-6999.154302","volume":"128","author":"S Li","year":"2015","unstructured":"Li S, Li J, Fei BY et al (2015a) MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor gamma. Chin Med J (Engl) 128(7):941\u2013947. https:\/\/doi.org\/10.4103\/0366-6999.154302","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"2749_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10529-014-1715-y","volume":"37","author":"T Li","year":"2015","unstructured":"Li T, Luo W, Liu K, Lv X, Xi T (2015b) miR-31 promotes proliferation of colon cancer cells by targeting E2F2. Biotechnol Lett 37(3):523\u2013532. https:\/\/doi.org\/10.1007\/s10529-014-1715-y","journal-title":"Biotechnol Lett"},{"issue":"6","key":"2749_CR36","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.3892\/mmr.2018.8880","volume":"17","author":"H Liang","year":"2018","unstructured":"Liang H, Sun H, Yang J, Yi C (2018) miR1455p reduces proliferation and migration of hepatocellular carcinoma by targeting KLF5. Mol Med Rep 17(6):8332\u20138338. https:\/\/doi.org\/10.3892\/mmr.2018.8880","journal-title":"Mol Med Rep"},{"issue":"4","key":"2749_CR37","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/jci39566","volume":"120","author":"X Liu","year":"2010","unstructured":"Liu X, Sempere LF, Ouyang H et al (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 120(4):1298\u20131309. https:\/\/doi.org\/10.1172\/jci39566","journal-title":"J Clin Invest"},{"issue":"1","key":"2749_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3892\/ijmm.2018.3637","volume":"42","author":"Z Liu","year":"2018","unstructured":"Liu Z, Sun J, Liu B, Zhao M, Xing E, Dang C (2018) miRNA222 promotes liver cancer cell proliferation, migration and invasion and inhibits apoptosis by targeting BBC3. Int J Mol Med 42(1):141\u2013148. https:\/\/doi.org\/10.3892\/ijmm.2018.3637","journal-title":"Int J Mol Med"},{"issue":"7385","key":"2749_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature10888","volume":"482","author":"A Lujambio","year":"2012","unstructured":"Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482(7385):347\u2013355. https:\/\/doi.org\/10.1038\/nature10888","journal-title":"Nature"},{"issue":"1","key":"2749_CR40","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1111\/j.1750-3841.2007.00597.x","volume":"73","author":"S Mahadevan","year":"2008","unstructured":"Mahadevan S, Park Y (2008) Multifaceted therapeutic benefits of Ginkgo biloba L: chemistry, efficacy, safety, and uses. J Food Sci 73(1):R14\u2013R19. https:\/\/doi.org\/10.1111\/j.1750-3841.2007.00597.x","journal-title":"J Food Sci"},{"issue":"8","key":"2749_CR41","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1872-034X.2009.00572.x","volume":"39","author":"T Masaki","year":"2009","unstructured":"Masaki T (2009) MicroRNA and hepatocellular carcinoma. Hepatol Res 39(8):751\u2013752. https:\/\/doi.org\/10.1111\/j.1872-034X.2009.00572.x","journal-title":"Hepatol Res"},{"issue":"1","key":"2749_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10590501.2016.1278298","volume":"35","author":"N Mei","year":"2017","unstructured":"Mei N, Guo XQ, Ren Z, Kobayashi D, Wada K, Guo L (2017) Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports. J Environ Sci Health 35(1):1\u201328. https:\/\/doi.org\/10.1080\/10590501.2016.1278298","journal-title":"J Environ Sci Health"},{"issue":"2","key":"2749_CR43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","volume":"133","author":"F Meng","year":"2007","unstructured":"Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133(2):647\u2013658. https:\/\/doi.org\/10.1053\/j.gastro.2007.05.022","journal-title":"Gastroenterology"},{"issue":"23","key":"2749_CR44","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4254\/wjh.v9.i23.1001","volume":"9","author":"AA Mohamed","year":"2017","unstructured":"Mohamed AA, Ali-Eldin ZA, Elbedewy TA, El-Serafy M, Ali-Eldin FA, AbdelAziz H (2017) MicroRNAs and clinical implications in hepatocellular carcinoma. World J Hepatol 9(23):1001\u20131007. https:\/\/doi.org\/10.4254\/wjh.v9.i23.1001","journal-title":"World J Hepatol"},{"issue":"1","key":"2749_CR45","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1038\/s41598-018-27521-y","volume":"8","author":"A Nagy","year":"2018","unstructured":"Nagy A, Lanczky A, Menyhart O, Gyorffy B (2018) Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep 8(1):9227. https:\/\/doi.org\/10.1038\/s41598-018-27521-y","journal-title":"Sci Rep"},{"key":"2749_CR46","unstructured":"NTP (2013) Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No 90045\u201336\u20136) in F344\/N rats and B6C3F1\/N mice (Gavage studies). Natl Toxicol Program Tech Rep Ser(578):1\u2013183"},{"issue":"7","key":"2749_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12094-015-1278-y","volume":"17","author":"L Pan","year":"2015","unstructured":"Pan L, Ren F, Rong M et al (2015) Correlation between down-expression of miR-431 and clinicopathological significance in HCC tissues. Clin Transl Oncol 17(7):557\u2013563. https:\/\/doi.org\/10.1007\/s12094-015-1278-y","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"2749_CR48","doi-asserted-by":"publisher","first-page":"14089","DOI":"10.18632\/oncotarget.12923","volume":"8","author":"Y Peng","year":"2017","unstructured":"Peng Y, Zhang X, Feng X, Fan X, Jin Z (2017) The crosstalk between microRNAs and the Wnt\/beta-catenin signaling pathway in cancer. Oncotarget 8(8):14089\u201314106. https:\/\/doi.org\/10.18632\/oncotarget.12923","journal-title":"Oncotarget"},{"key":"2749_CR49","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.indcrop.2013.09.011","volume":"51","author":"E Pereira","year":"2013","unstructured":"Pereira E, Barros L, Ferreira I (2013) Chemical characterization of Ginkgo biloba L. and antioxidant properties of its extracts and dietary supplements. Ind Crops Prod 51:244\u2013248. https:\/\/doi.org\/10.1016\/j.indcrop.2013.09.011","journal-title":"Ind Crops Prod"},{"key":"2749_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12943-015-0337-x","volume":"14","author":"SA Rasheed","year":"2015","unstructured":"Rasheed SA, Teo CR, Beillard EJ et al (2015) MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells. Mol Cancer 14:67. https:\/\/doi.org\/10.1186\/s12943-015-0337-x","journal-title":"Mol Cancer"},{"issue":"5","key":"2749_CR51","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1177\/0192623313501235","volume":"42","author":"CV Rider","year":"2014","unstructured":"Rider CV, Nyska A, Cora MC et al (2014) Toxicity and carcinogenicity studies of Ginkgo biloba extract in rat and mouse: liver, thyroid, and nose are targets. Toxicol Pathol 42(5):830\u2013843. https:\/\/doi.org\/10.1177\/0192623313501235","journal-title":"Toxicol Pathol"},{"issue":"7","key":"2749_CR52","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2749_CR53","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/cgt.2015.41","volume":"22","author":"W Ruoming","year":"2015","unstructured":"Ruoming W, Zhen Y, Tengteng Z, Jisheng H (2015) Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2. Cancer Gene Ther 22(12):564\u2013572. https:\/\/doi.org\/10.1038\/cgt.2015.41","journal-title":"Cancer Gene Ther"},{"key":"2749_CR54","unstructured":"Saper RB (2014) Clinical use of Ginkgo biloba. UpToDate, Inc https:\/\/www.uptodatecom\/contents\/clinical-use-of-ginkgo-biloba"},{"issue":"6","key":"2749_CR55","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101\u20131108","journal-title":"Nat Protoc"},{"issue":"5","key":"2749_CR56","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/hep.28679","volume":"64","author":"A Simerzin","year":"2016","unstructured":"Simerzin A, Zorde-Khvalevsky E, Rivkin M et al (2016) The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53\/mouse double minute 2 homolog circuitry. Hepatology 64(5):1623\u20131636. https:\/\/doi.org\/10.1002\/hep.28679","journal-title":"Hepatology"},{"issue":"4","key":"2749_CR57","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/odi.12118","volume":"20","author":"MY Siow","year":"2014","unstructured":"Siow MY, Ng LP, Vincent-Chong VK et al (2014) Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma. Oral Dis 20(4):345\u2013351. https:\/\/doi.org\/10.1111\/odi.12118","journal-title":"Oral Dis"},{"key":"2749_CR58","first-page":"62","volume":"123","author":"TGM Smith","year":"2019","unstructured":"Smith TGM, Eckl V, Knepper J, Reynolds CM (2019) Herbal supplement sales in US increase by 9.4% in 2018. HerbalGram 123:62\u201373","journal-title":"HerbalGram"},{"issue":"24","key":"2749_CR59","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1001\/jama.2009.1913","volume":"302","author":"BE Snitz","year":"2009","unstructured":"Snitz BE, O'Meara ES, Carlson MC et al (2009) Ginkgo biloba for preventing cognitive decline in older adults a randomized trial. Jama-J Am Med Assoc 302(24):2663\u20132670. https:\/\/doi.org\/10.1001\/jama.2009.1913","journal-title":"Jama-J Am Med Assoc"},{"issue":"6","key":"2749_CR60","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ijc.25793","volume":"129","author":"K Sossey-Alaoui","year":"2011","unstructured":"Sossey-Alaoui K, Downs-Kelly E, Das M, Izem L, Tubbs R, Plow EF (2011) WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade. Int J Cancer 129(6):1331\u20131343. https:\/\/doi.org\/10.1002\/ijc.25793","journal-title":"Int J Cancer"},{"issue":"6","key":"2749_CR61","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.cell.2009.03.047","volume":"137","author":"S Valastyan","year":"2009","unstructured":"Valastyan S, Reinhardt F, Benaich N et al (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137(6):1032\u20131046. https:\/\/doi.org\/10.1016\/j.cell.2009.03.047","journal-title":"Cell"},{"key":"2749_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/J.Fct.2019.110586","author":"S Waidyanatha","year":"2019","unstructured":"Waidyanatha S, Mutlu E, Gibbs S et al (2019) Systemic exposure to Ginkgo biloba extract in male F344\/NCrl rats: relevance to humans. Food Chem Toxicol. https:\/\/doi.org\/10.1016\/J.Fct.2019.110586","journal-title":"Food Chem Toxicol"},{"issue":"19","key":"2749_CR63","doi-asserted-by":"publisher","first-page":"13205","DOI":"10.1074\/jbc.M707629200","volume":"283","author":"Y Wang","year":"2008","unstructured":"Wang Y, Lee AT, Ma JZ et al (2008) Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 283(19):13205\u201313215. https:\/\/doi.org\/10.1074\/jbc.M707629200","journal-title":"J Biol Chem"},{"issue":"2","key":"2749_CR64","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/epi.11.5","volume":"3","author":"Y Wang","year":"2011","unstructured":"Wang Y, Lee CG (2011) Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention? Epigenomics 3(2):235\u2013243. https:\/\/doi.org\/10.2217\/epi.11.5","journal-title":"Epigenomics"},{"issue":"7","key":"2749_CR65","doi-asserted-by":"publisher","first-page":"e68744","DOI":"10.1371\/journal.pone.0068744","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang Y, Ren J, Gao Y et al (2013) MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival. PLoS ONE 8(7):e68744. https:\/\/doi.org\/10.1371\/journal.pone.0068744","journal-title":"PLoS ONE"},{"issue":"6","key":"2749_CR66","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2217\/epi.10.51","volume":"2","author":"ED Wiklund","year":"2010","unstructured":"Wiklund ED, Kjems J, Clark SJ (2010) Epigenetic architecture and miRNA: reciprocal regulators. Epigenomics 2(6):823\u2013840. https:\/\/doi.org\/10.2217\/epi.10.51","journal-title":"Epigenomics"},{"issue":"3","key":"2749_CR67","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1158\/1078-0432.Ccr-09-1840","volume":"16","author":"QW Wong","year":"2010","unstructured":"Wong QW, Ching AK, Chan AW et al (2010) MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res 16(3):867\u2013875. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-09-1840","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2749_CR68","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.urolonc.2009.08.024","volume":"29","author":"MF Wszolek","year":"2011","unstructured":"Wszolek MF, Rieger-Christ KM, Kenney PA et al (2011) A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urol Oncol 29(6):794\u2013801. https:\/\/doi.org\/10.1016\/j.urolonc.2009.08.024","journal-title":"Urol Oncol"},{"issue":"15","key":"2749_CR69","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1016\/j.ejca.2010.06.127","volume":"46","author":"C Xu","year":"2010","unstructured":"Xu C, Liu S, Fu H et al (2010) MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. Eur J Cancer 46(15):2828\u20132836. https:\/\/doi.org\/10.1016\/j.ejca.2010.06.127","journal-title":"Eur J Cancer"},{"issue":"19","key":"2749_CR70","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.7150\/jca.26350","volume":"9","author":"X Xu","year":"2018","unstructured":"Xu X, Tao Y, Shan L et al (2018) The role of MicroRNAs in hepatocellular carcinoma. J Cancer 9(19):3557\u20133569. https:\/\/doi.org\/10.7150\/jca.26350","journal-title":"J Cancer"},{"issue":"1","key":"2749_CR71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2105-7-85","volume":"7","author":"JS Yuan","year":"2006","unstructured":"Yuan JS, Reed A, Chen F, Stewart CN (2006) Statistical analysis of real-time PCR data. BMC Bioinform 7(1):85. https:\/\/doi.org\/10.1186\/1471-2105-7-85","journal-title":"BMC Bioinform"},{"issue":"2","key":"2749_CR72","doi-asserted-by":"publisher","first-page":"e87665","DOI":"10.1371\/journal.pone.0087665","volume":"9","author":"R Zha","year":"2014","unstructured":"Zha R, Guo W, Zhang Z et al (2014) Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin beta1 in hepatocellular carcinoma. PLoS ONE 9(2):e87665. https:\/\/doi.org\/10.1371\/journal.pone.0087665","journal-title":"PLoS ONE"},{"issue":"2","key":"2749_CR73","first-page":"1231","volume":"9","author":"JK Zhang","year":"2016","unstructured":"Zhang JK, Luo HF, Du J, Liu YP (2016) MicroRNA-300 plays as oncogene by promoting proliferation and reducing apoptosis of liver cancer cells by targeting MDC1. Int J Clin Exp Pathol 9(2):1231\u20131239","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"2749_CR74","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.canlet.2014.11.013","volume":"356","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Yao J, Huan L et al (2015) GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma. Cancer Lett 356(2):978\u2013984. https:\/\/doi.org\/10.1016\/j.canlet.2014.11.013","journal-title":"Cancer Lett"},{"issue":"2","key":"2749_CR75","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbrc.2017.06.050","volume":"490","author":"G Zhao","year":"2017","unstructured":"Zhao G, Han C, Zhang Z, Wang L, Xu J (2017) Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line. Biochem Biophys Res Commun 490(2):371\u2013377. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.050","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2749_CR76","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1007\/s13277-015-4109-4","volume":"37","author":"J Zhou","year":"2016","unstructured":"Zhou J, Li W, Guo J, Li G, Chen F, Zhou J (2016) Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma. Tumour Biol 37(3):3561\u20133569. https:\/\/doi.org\/10.1007\/s13277-015-4109-4","journal-title":"Tumour Biol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-020-02749-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02749-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T07:55:50Z","timestamp":1722758150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-020-02749-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,18]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2749"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02749-8","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"type":"print","value":"0340-5761"},{"type":"electronic","value":"1432-0738"}],"subject":[],"published":{"date-parts":[[2020,4,18]]},"assertion":[{"value":"14 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declared no potential, real, or perceived conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}